Infratrac is developing a new near-infrared (NIR) spectroscopy-based technique to identify biomolecules and assess their measure of quality or state of degradation

Ended Cooperative Agreement Awarded

Award ID
70NANB22H189
Recipient
Awarding agency
Obligated
$100,000

Award facts

Assistance listing
11.620 Science, Technology, Business and/or Education Outreach
Completion date
Place of performance
Silver Spring, MD 20910, USA

Award details come from USAspending.gov.

Description

Activities
Infratrac will collect NIR spectra of known ingredient specimens utilized in 3D drug-printing. The company will use advanced computational algorithms to conduct analyses and correlate spectra to known pharmaceuticals. The demonstration tests will be applied to known drugs including acetaminophen.
Expected outcomes
Infratrac will create a library of NIR spectroscopic standards, test NIR modeling against standard pharmaceutical quality measures, and define a data framework for in-process NIR for 3D printers.
Intended beneficiaries
The technology will support patients in receiving personalized medical care with drugs customized to their size, metabolism, allergies, genetics, and taste.
Subrecipient activities
There are no subrecipients in this project.

Quick answers

Who received award 70NANB22H189?

70NANB22H189 was awarded to Infratrac Inc. by National Institute of Standards and Technology (Department of Commerce) on September 20, 2022.

How much is award 70NANB22H189 worth?

$100,000 has been obligated on 70NANB22H189.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award